The enhanced dependence on the BMP/SMAD1/5/9 pathway in SMAD4-deficient contexts could potentially explain why CHRDL1 exhibits more pronounced metastasis-suppressing effects in pancreatic cancer (34). This evidence concerns the gene SMAD4 and pancreatic neoplasm.